FDAnews Drug Daily Bulletin

Two Supplement Makers Get Warning Letters for False Advertising

Aug. 9, 2016

The FDA is faulting two online supplement distributors for marketing a multitude of products online with drug-like claims.

Agency officials reviewed Hsu’s Ginseng Enterprises’ two websites and found the company was promoting 11 products using language reserved for prescription drug products. For example, the FDA’s warning letter notes that the company claims its Ejia black soybean powder can “prevent diabetes” and “remove anemia.”

Similarly, the company’s Alaska fish oil was promoted for its supposed ability to “lower LDL cholesterol” levels.

View today's stories